Top Markets
Coin of the day
Augmedix, Inc. Augmedix, Inc.

Augmedix, Inc.

AUGX
Rangering i aksjer #22478
Augmedix, Inc. is a U.S.-based company specializing in remote medical... Augmedix, Inc. is a U.S.-based company specializing in remote medical documentation and offering live support to clinical professionals. Its comprehensive platform, comprising Augmedix Live and Augmedix Notes, streamlines the entire documentation process for patient encounters. This includes preparatory tasks like pre-charting and digitizing historical patient data prior to appointments. During the consultation, it generates essential medical notes, flags care gaps, provides HCC reminders, and produces after-visit summaries. Post-visit, the system facilitates crucial administrative duties such as medical coding, processing orders, and managing referrals. Clinicians can readily access these applications via mobile devices, including smartphones or specialized wearables like Google Glass. The company's clientele primarily consists of various health systems and distinct specialty groups. Founded in 2013, Augmedix maintains its corporate headquarters in San Francisco, California.
Aksjekurs
$2.35
Sist synkronisert: 2024-10-02
Markedsverdi
$87.95M
Endring (1 dag)
0.00%
Endring (1 år)
0.00%
Land
US
Handel Augmedix, Inc. (AUGX)

Kategori

Inntekter for Augmedix, Inc. (AUGX)
Inntekter i Jun 2024 TTM: $-23.87M
Ifølge Augmedix, Inc. sine nyeste økonomiske rapporter er selskapets nåværende resultat $-23.87M. I 2022 hadde selskapet et resultat på $-24.45M, en nedgang sammenlignet med resultatet i 2021, som var $-17.85M. Resultatet som vises på denne siden er resultat før renter og skatt, eller EBIT.
Inntektshistorikk for Augmedix, Inc. fra 2018 til 2026
Inntekter ved slutten av hvert år
År Inntekter Endre
2026 (TTM) $-23.87M 25.43%
2023 $-19.03M -22.18%
2022 $-24.45M 36.96%
2021 $-17.85M 14.40%
2020 $-15.60M -15.65%
2019 $-18.50M -23.44%
2018 $-24.16M 0.00%
Inntekter for lignende selskaper eller konkurrenter
Selskap Inntekter Forskjell i inntekter Land
$2.04B -8,660.65%
US
$266.26M -1,215.68%
AU
$-259.89M 989.02%
US
$295.53M -1,338.35%
US
- -
US